| Code | 41162 | ||||||||||
| MA number | EU/1/01/198/010 | ||||||||||
| Product Form: | tbl flm 30x400 mg (blis.PVDC/Al) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Novartis Europharm Limited, Ireland | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 07.11.2001 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC letter_BCR-ABLTKIs_SK 11 4 2016.pdf
|
| Safety feature | Yes |
| Data update: | 30.08.2021 |
